ID   1H11 [Mouse hybridoma against human COL1A2]
AC   CVCL_J166
DR   CLO; CLO_0001171
DR   ATCC; HB-10611
DR   Wikidata; Q54582903
RX   Patent=US5300434;
RX   Patent=US5677198;
RX   PubMed=1466251;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10611.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08123; Human COL1A2 (Note=Recognizes cross-linked N-telopeptides "QYDGKGVG" where K is involved in trivalent cross-linking).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
RX   Patent=US5300434;
RA   Eyre D.R.;
RT   "Hybridoma cell line producing an antibody to type-I collagen
RT   amino-terminal telopeptide.";
RL   Patent number US5300434, 05-Apr-1994.
//
RX   Patent=US5677198;
RA   Eyre D.R.;
RT   "Assay for peptide metabolites from the amino-terminal telopeptide
RT   domain of type I collagen.";
RL   Patent number US5677198, 14-Oct-1997.
//
RX   PubMed=1466251; DOI=10.1002/jbmr.5650071119;
RA   Hanson D.A., Weis M.A.E., Bollen A.-M., Maslan S.L., Singer F.R.,
RA   Eyre D.R.;
RT   "A specific immunoassay for monitoring human bone resorption:
RT   quantitation of type I collagen cross-linked N-telopeptides in
RT   urine.";
RL   J. Bone Miner. Res. 7:1251-1258(1992).
//